View Item 

Show simple item record

A striking presentation of pustular Sweet syndrome induced by trimethoprim-sulfamethoxazole
dc.contributor.authorRyder, C. Yoonhee
dc.contributor.authorMatthews, Natalie H.
dc.contributor.authorLowe, Lori
dc.contributor.authorWang, Frank
dc.date.accessioned2022-12-05T16:42:16Z
dc.date.available2023-12-05 11:42:13en
dc.date.available2022-12-05T16:42:16Z
dc.date.issued2022-11
dc.identifier.citationRyder, C. Yoonhee; Matthews, Natalie H.; Lowe, Lori; Wang, Frank (2022). "A striking presentation of pustular Sweet syndrome induced by trimethoprim-sulfamethoxazole." Australasian Journal of Dermatology (4): e356-e359.
dc.identifier.issn0004-8380
dc.identifier.issn1440-0960
dc.identifier.urihttps://hdl.handle.net/2027.42/175249
dc.description.abstractWe describe a strikingly robust presentation of trimethoprim-sulfamethoxazole (TMP-SMX)-induced pustular Sweet syndrome and discuss how to distinguish it from iododerma and other neutrophil-rich conditions. A review of the literature indicates that TMP-SMX-induced Sweet syndrome (SS) may have higher rates of neutrophilia and greater ocular, mucosal, and musculoskeletal involvement compared to SS from other drugs. Recognizing these features and identifying the offending agent are critical for correctly diagnosing TMP-SMX-induced SS in a timely manner.
dc.publisherWiley Periodicals, Inc.
dc.subject.otherSweet syndrome
dc.subject.otherdrug hypersensitivity
dc.subject.otherneutrophils
dc.subject.otherpotassium iodide
dc.subject.othertrimethoprim, sulfamethoxazole drug combination
dc.subject.otherdrug eruptions
dc.titleA striking presentation of pustular Sweet syndrome induced by trimethoprim-sulfamethoxazole
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelDermatology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/175249/1/ajd13897_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/175249/2/ajd13897.pdf
dc.identifier.doi10.1111/ajd.13897
dc.identifier.sourceAustralasian Journal of Dermatology
dc.identifier.citedreferenceTam C, Ingraffea A. Sweet syndrome presenting with an unusual morphology. Cutis. 2015; 96 ( 2 ): 9 – 10.
dc.identifier.citedreferenceRochet NM, Chavan RN, Cappel MA, Wada DA, Gibson LE. Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients. J Am Acad Dermatol. 2013; 69 ( 4 ): 557 – 64. https://doi.org/10.1016/j.jaad.2013.06.023
dc.identifier.citedreferenceKhaled A, Kharfi M, Fazaa B, Kourda M, Bouaziz A, Kastalli S, et al. A first case of trimethoprim-sulfamethoxazole induced Sweet’s syndrome in a child. Pediatr Dermatol. 2009; 26 ( 6 ): 744 – 6. https://doi.org/10.1111/j.1525-1470.2009.00868.x
dc.identifier.citedreferenceRoujeau JC. Neutrophilic drug eruptions. Clin Dermatol. 2000; 18 ( 3 ): 331 – 7. https://doi.org/10.1016/s0738-081x(99)00124-8
dc.identifier.citedreferenceCohen P. Sweet’s syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis. 2007; 2 ( 34 ): 1750 – 172. https://doi.org/10.1186/1750-1172-2-34
dc.identifier.citedreferenceWalker D, Cohen P. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet’s syndrome. J Am Acad Dermatol. 1996; 34 ( 5 ): 918 – 23. https://doi.org/10.1016/s0190-9622(96)90080-8
dc.identifier.citedreferenceSarkany RP, Burrows NP, Grant JW, Pye RJ, Norris PG. The pustular eruption of ulcerative colitis: a variant of Sweet’s syndrome? Br J Dermatol. 1998; 138 ( 2 ): 365 – 6. https://doi.org/10.1046/j.1365-2133.1998.02099.x
dc.identifier.citedreferenceGkrouzman E, Chirch L, Lakshminarayanan S. Drug-induced Sweet syndrome in a man with sarcoidosis: are there any common mechanisms of pathogenesis? J Clin Rheumatol. 2019; 25 ( 7 ): 122 – 6. https://doi.org/10.1097/RHU.0000000000000730
dc.identifier.citedreferenceKluger N, Marque M, Stoebner PE, Dandurand M, Meunier L. Possible drug-induced Sweet’s syndrome due to trimethoprim-sulphamethoxazole. Acta Derm Venereol. 2008; 88: 637 – 8. https://doi.org/10.2340/00015555-0516
dc.identifier.citedreferenceSaxe N, Gordon W. Acute febrile neutrophilic dermatosis (Sweet’s syndrome). S Afr Med J. 1978; 53 ( 253 ): 253 – 6.
dc.identifier.citedreferenceShaikh M, Krunic A. Drug-induced Sweet syndrome. J Allergy Clin Immunol Pract. 2019; 7 ( 7 ): 2400 – 1. https://doi.org/10.1016/j.jaip.2019.07.002
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ajd13897_am.pdf
Size:
5.901MB
Format:
PDF
View/Open
Name:
ajd13897.pdf
Size:
1.004MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.